Evaluation of cross-resistance between responses to cisplatin, hyperthermia, and radiation in human glioma cells and eight clones selected for cisplatin resistance

Radiation Oncology Investigations

Volumn 7, Issue 3, 1999, Pages 153-157

  Raaphorst, G P ^a   Wilkins, D E ^a   Mao, J P ^a   Miao, J C ^a   Ng, C E ^a  

^a OTTAWA REGIONAL CANCER CENTRE   (Canada)

Author keywords

Cisplatin resistance; Cross resistance; Glioma; Hyperthermia; Radiation

Indexed keywords

CISPLATIN;

ARTICLE; CELL CLONE; CELL SURVIVAL; CONCENTRATION RESPONSE; CROSS RESISTANCE; GLIOMA CELL; HUMAN; HUMAN CELL; HYPERTHERMIA; PRIORITY JOURNAL; RADIATION; RADIOSENSITIVITY;

ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CELL SURVIVAL; CISPLATIN; CLONE CELLS; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; DRUG RESISTANCE, NEOPLASM; EVALUATION STUDIES; GLIOMA; HUMANS; HYPERTHERMIA, INDUCED; RADIOTHERAPY DOSAGE; SENSITIVITY AND SPECIFICITY; TUMOR CELLS, CULTURED;

EID: 0033061289     PISSN: 10657541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6823(1999)7:3<153::AID-ROI3>3.0.CO;2-T     Document Type: Article

References (40)

1. Canon JL, Humblet Y, Symann M. Resistance to cisplatin: how to deal with the problem? Eur J Cancer 1990;26:1-3.
2. Bosscha HT, Mulder NH, de Vries ECG. Modulation of cis-diamminedichloroplatinum (II) resistance: a review. Br J Cancer 1991;66:227-238.
3. Fujii R, Mutak M, Niwa K et al. Active efflux for cisplatin in cisplatin-resistant human KB cells. Jpn J Cancer Res 1994;85:426-433.
4. Jekunen AP, Hom DK, Alcaraz JE et al. Cellular pharmacology of dichloro(ethylenediamine) platin II in cisplatin-sensitive and resistant human ovarian carcinoma cells. Cancer Res 1994;54:2680-2687.
5. Eastman A, Schulte N. Enhanced DNA repair as a mechanism of resistance to cis-diaminedichloroplatinum (II). Biochemistry 1988;27:4730-4734.
6. Meyer C, Mulder NH, Hospers GAP et al. The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line. Br J Cancer 1990;62:72-77.
7. Masuda H, Ozols RF, Lai GM et al. Increased DNA repair as a mechanism of acquired resistance to cis-diaminedichloroplatinum II in human ovarian cancer cell lines. Cancer Res 1988;48:5713-5716.
8. Raaphorst GP, Wang G, Ng CE. Radiosensitization by cisplatin treatment in cisplatin resistant and sensitive human ovarian carcinoma cell lines. Int J Oncol 1995; 7:325-330.
9. Engelhardt R. Hyperthermia and drugs. Recent Results Cancer Res 1987;104:136-203.
10. DaSilva VF, Raaphorst GP, Goyal R et al. Drug cytotoxicity at elevated temperature. J Neurosurg 1987;67: 885-888.
11. Urano M, Kahn J, Majima H et al. The cytotoxic effect of cis-diamminedichloroplatinum (II) on cultured Chinese hamster ovary cells at elevated temperatures. Arrhenius plot analysis. Int J Hyperthermia 1990;6:581-590.
12. Raaphorst GP, Doja S, Davis L et al. Comparison of cisplatin-hyperthermia sensitization in human ovarian carcinoma and glioma cell lines sensitive and resistant to cisplatin treatment. Cancer Chemother Pharmacol 1996;37:574-580.
13. Kubuta N, Kakehi M, Inada T. Hyperthermic enhancement of cell killing by five platinum complexes in human malignant melanoma cells grown as monolayer cultures and multicellular spheroids. Int J Radiat Oncol 1993;25:491-497.
14. Herman TS, Teicher BA, Cathcart FNS et al. Effect of hyperthermia on cisdiaminedichloroplatinum (II) and pt (Rh-123) in a human squamous carcinoma cell line and a cisplatin resistant subline. Cancer Res 1988;48:5101-5105.
15. Hettinga JVE, Lemstra W, Mayer C et al. Hyperthermic potentiation of cisplatin toxicity in human small cell lung carcinoma cell line and a cisplatin resistant subline. Int J Hyperthermia 1994;10:795-805.
16. Eichholtz-Wirth H, Hietel B. Heat sensitization to cis-platin in two cell lines with different drug sensitivities. Int J Hyperthermia 1990;6:47-55.
17. Konings AWT, Hettinga JVE, Lemstra W et al. Sensitizing for cisplatin action by hyperthermia in resistant cells. Int J Hyperthermia 1993;9:553-562.
18. Masuda H, Tanaka T, Kido A et al. Hyperthermic enhancement of cytotoxicity and DNA-binding of cisplatin in sensitive and resistant human ovarian cancer cell lines. Cancer J 1991;4:283-287.
19. Hettinga JVE, Konings AWT, Kampinga HH. Reduction of cellular cisplatin resistance by hyperthermia - a review. Int J Hyperthermia 1997;13:439-457.
20. Begg A, Bohlen S, Bartelink S. The effect of cisplatin on repair of radiation damage in RIFI mouse tumours in vivo. Radiother Oncol 1989;15:79-81.
21. Begg AC, Stewart FA, Dewit L et al. Interactions between cisplatin and radiation in experimental rodent tumours and normal tissues. In: Hill BT, Bellamy AS, editors. Antitumour drug-radiation interactions. Boca Raton, FL: CRC Press; 1990, p 153-170.
22. Dewit L, Bartelink H, Rumke PH. Concurrent cis-diamminedichloroplatinum (II) and radiation treatment for melanoma metastases: a pilot study. Radiother Oncol 1985;3:303-309.
23. Dritschilo A, Piro A, Kelman AD. The effect of cis-platinum on the repair of radiation damage in plateau phase Chinese hamster V79 cells. Int J Radiat Oncol 1979;5:1345-1349.
24. Nias AHW. Radiation and platinum drug interaction. Int J Radiat Biol 1985;48:297-314.
25. Wilkins DE, Raaphorst GP, Heller DP. Inhibition of potentially lethal damage recovery by cisplatin in the 9L rat brain cell. Anticancer Res 1993;13:2137-2142.
26. Walter P, Korbelik M, Spadinger I et al. Investigations into mechanisms of the interaction between platinum complexes and irradiation at low (2 Gy) doses in hypoxic cells: role of single strand breaks. Radiat Oncol Invest 1993;1:137-147.
27. Raaphorst GP, Yang DP, Grewaal D et al. Analysis of mechanisms of cisplatin resistance in three pairs of human tumour cell lines expressing normal and resistant responses to cisplatin. Oncol Rep 1995;2:1037-1043.
28. Schwachofer JHM, Crooijmans RPMA, Hoogenhout J et al. Effectiveness in inhibition of recovery of cell survival by cisplatin and carboplatin influence of treatment sequence. Int J Radiat Oncol 1991;20:1235-1241.
29. Szumiel I, Nias AHW. The effect of combined treatment with a platinum complex and ionizing radiation of Chinese hamster ovary cells in vitro. Br J Cancer 1976; 33:450-458.
30. Douple EB. Interaction between cisplatin coordination complexes and radiation. In: Hill BT, Bellamy AS, editors. Antitumour drug-radiation interactions. Boca Raton, FL: CRC Press; 1990, p 171-190.
31. Wilkins DE, Ng CE, Raaphorst GP. Cisplatin and low dose rate irradiation in cisplatin resistant and sensitive human glioma cells. Int J Radiat Oncol 1996;36:105-111.
32. Britten RA, Warenius HM, Carraway AV et al. Differential modulation of radiosensitivity following induction of cis-platinum resistance in radiation-sensitive and radiation-resistant human tumour cells. Radiat Oncol Invest 1994;2:24-31.
33. Wallner KE, Li GC. Effect of cisplatin resistance on cellular radiation response. Int J Radiat Oncol 1987;13: 587-591.
34. Schwartz JL, Rolmensch J, Beckett MA et al. X-ray and cis-diamminedichloroplatinum (II) cross-resistance in human tumour cell lines. Cancer Res 1988;48:5133-5135.
35. Oshita F, Fujiwara Y, Saigo N. Radiation sensitivities in various anticancer drug resistant human lung cancer cell lines and mechanism of radiation cross-resistance in a cisplatin-resistant cell line. J Cancer Res Clin Oncol 1992;119:28-34.
36. Raaphorst GP, Yang H, Wilkins DE, Ng CE. Combination treatment of cisplatin, hyperthermia and low dose rate irradiation in human ovarian carcinoma cells resistant and sensitive to cisplatin treatment. Int J Hyperthermia 1996;12:801-812.
37. Raaphorst GP, Miao J, Ng CE. Cisplatin and mild hyperthermia in radiosensitization to low dose rate irradiation in human ovarian carcinoma cells. Anticancer Res 1998;17:3469-3472.
38. Herman TS, Teicher BA. Sequencing of trimodality therapy (cisdiaminedichloroplatinum/hyperthermia/ radiation) as determined by tumour growth delay and tumour cell survival in the Fsa II C fibrosarcoma. Cancer Res 1988;48:2693-2697.
39. Herman TS, Jochelson MS, Teicher BA. A phase I-II trial of cisplatin, hyperthermia and radiation in patients with locally advanced malignancies. Int J Radiat Oncol 1990;17:1273-1279.
40. Feyerabend T, Steeves R, Wiedemann GJ, Richter E, Robins HI. Rationale and clinical status of local hyperthermia, radiation and chemotherapy in locally advanced malignancies. Anticancer Res 1997;17:2895-2898.